Skip to main content
Back to New Enterprise Associates

New Enterprise Associates's Pharmaceutical Portfolio

Browse 8 Pharmaceutical companies funded by New Enterprise Associates. See funding amounts, founder contacts, and investment details.

Pharmaceutical Companies
8
Total Funding in Pharmaceutical
$528.2M

Pharmaceutical Portfolio Companies (8)

Export
BiotechnologyHealth CarePharmaceuticalTherapeutics

Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies.

Foster City, United States
May 2026
Post-IPO Debt

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Trevi Therapeutics is a clinical-stage biopharmaceutical company that develops drugs for treating uremic pruritus.

Sandy Hook, United States
April 2026
Post-IPO Equity

Founder Contacts

19,000+ verified contacts

BiopharmaHealth CarePharmaceutical

Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.

Waltham, United States
March 2026
$100.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyLife ScienceMedicalPharmaceutical

Splice Bio develops gene therapies using its Protein Splicing platform for genetic diseases.

Barcelona, Spain
June 2025
$135.0M
Series B

Founder Contacts

19,000+ verified contacts

DeliveryMedicalPharmaceutical

Spyglass Pharma provides medicine for ophthalmic diseases.

Aliso Viejo, United States
June 2025
$75.0M
Series D

Founder Contacts

19,000+ verified contacts

Health CareMedicalPharmaceuticalTherapeutics

Orbis Medicines is a novel macrocyclic chemistry and computational platform for oral macrocycle drug discovery.

Frederiksberg, Denmark
January 2025
$93.2M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

858 Therapeutics develops small molecule drugs targeting oncology and immunology.

San Diego, United States
September 2024
$50.0M
Series B

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

Our purpose is to make every pregnancy around the world safer.

Concord, United States
January 2024
$75.0M
Series B

Founder Contacts

19,000+ verified contacts

Explore New Enterprise Associates's Full Portfolio

View all companies funded by New Enterprise Associates across every industry and funding stage.

View Full New Enterprise Associates Portfolio